RxDoctor Payments Data

Aesha Singh, MD

Rheumatology · Huntington, WVNPI 1134649056

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 33.1% of the total. 2024 is the largest year on record at $1,045, 9.6 times the $109 reported in 2022.

$2,167in general payments, 2019–2025

Across 90 payments — averaging $24.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$717
  • Amgen$260
  • Johnson & Johnson$247
  • UCB, Inc.$219
  • Novartis$203
  • AstraZeneca$161
  • plus $359 from 13 others

What the payments were for

  • Food & beverage$2,167100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,167 in reported general payments places this provider in the 55th percentile of 26 rheumatology providers in West Virginia.

See all rheumatology providers in West Virginia

Medicare billing

Part B allowed, 2024
$35,474
Medicare patients
110
Services billed
692

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Orencia ClickjectAbatacept36$200,698
Humira(Cf) PenAdalimumab25$188,309
Cosentyx Sensoready (2 Pens)Secukinumab11$84,609
Hydroxychloroquine Sulfate128$7,250
MethotrexateMethotrexate Sodium80$4,439
Diclofenac Sodium34$1,528
Prednisone197$1,260
Colchicine38$1,088
Sulfasalazine36$1,021
Celecoxib38$1,010
Gabapentin23$762
Duloxetine Hcl20$746
Methylprednisolone14$496
Pregabalin23$415
Allopurinol30$386

Paid to pharmacies, not to this prescriber.

Other rheumatology in Huntington

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →